Phenobarbital

Phenobarbital

SCHEMBL7775273

CCC1(c2ccccc2)C(=O)NC(=O)NC1=O.O=C1CC(=O)NC(O)=N1

nearest known ligand 0.62

Full drug profile on Sugi Atlas →

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
MMP9 P14780 7/20 0.53
MMP2 P08253 6/20 0.53
MMP3 P08254 3/20 0.53
KMT2A Q03164 2/20 0.49
MEN1 O00255 1/20 0.49
CYP1A2 P05177 1/20 0.49
POLB P06746 1/20 0.49
TSHR P16473 1/20 0.49
APEX1 P27695 1/20 0.49
TDP1 Q9NUW8 1/20 0.49
LMNA P02545 3/20 0.43
MMP13 P45452 2/20 0.40
CYP2C19 P33261 1/20 0.40
MMP8 P22894 2/20 0.37
GSK3A P49840 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Phenobarbital SCHEMBL18825042 0.79 MMP2 (0.80) MMP9MMP2MMP3KMT2AMEN1
Phenobarbital SCHEMBL16583 0.79 MMP2 (0.80) MMP9MMP2MMP3KMT2AMEN1
Phenobarbital SCHEMBL2592325 0.79 MMP2 (0.80) MMP9MMP2MMP3KMT2AMEN1
Phenobarbital SCHEMBL28099657 0.79 MMP2 (0.80) MMP9MMP2MMP3KMT2AMEN1
Phenobarbital SCHEMBL11529160 0.78 MMP9 (0.73) MMP9MMP2MMP3KMT2AMEN1
Phenobarbital SCHEMBL1322895 0.78 MMP2 (0.77) MMP9MMP2MMP3KMT2AMEN1
Phenobarbital SCHEMBL352763 0.78 MMP2 (0.77) MMP9MMP2MMP3KMT2AMEN1
Phenobarbital SCHEMBL22032658 0.78 MMP2 (0.77) MMP9MMP2MMP3KMT2AMEN1
Phenobarbital SCHEMBL2120028 0.78 MMP2 (0.77) MMP9MMP2MMP3KMT2AMEN1
Phenobarbital SCHEMBL3475428 0.78 MMP2 (0.77) MMP9MMP2MMP3KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0517327-B1 Immunoassay with labeled hapten analogues JOHNSON & JOHNSON CLIN DIAG (US) 2001-08-16 EP disclosed
US-5601994-A Immunoassay with novel labeled drug hapten analogues JOHNSON & JOHNSON CLINICAL DIAGNOSTICS, INC. (US) 1997-02-11 US disclosed
EP-0517327-A2 Immunoassay with labeled hapten analogues Johnson & Johnson Clinical Diagnostics, Inc. (US) 1992-12-09 EP disclosed